Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4839)
All Articles published online
|
Feb 28, 2012 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, Chang TS, Lin YH. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol 2012; 18(8): 746-753 [PMID: 22371634 DOI: 10.3748/wjg.v18.i8.746] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i8/746.htm |
| Number | Citing Articles |
| 1 |
Thomas Pembroke, Giada Sebastiani. Diagnostic Methods for Cirrhosis and Portal Hypertension. 2018; : 63 doi: 10.1007/978-3-319-72628-1_5
|
| 2 |
Mette J. Nielsen, Konstantin Kazankov, Diana J. Leeming, Morten A. Karsdal, Aleksander Krag, Francisco Barrera, Duncan McLeod, Jacob George, Henning Grønbæk, Matias A Avila. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients. PLOS ONE 2015; 10(9): e0137302 doi: 10.1371/journal.pone.0137302
|
| 3 |
Jing Ma, Yongfang Jiang, Guozhong Gong. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. European Journal of Gastroenterology & Hepatology 2013; 25(4): 428 doi: 10.1097/MEG.0b013e32835cb5dd
|
| 4 |
Ayfer BAKIR, Mustafa GÜNEY, Harun ERDAL, Özlem YAVUZ, Armağan GÜNAL, Mustafa GÜLŞEN, Mehmet Tevfik YAVUZ. Assessment of The Performances of Hepatitis C Virus Viral Markers, Age-Platelet Index and Aspartate aminotransferase to Alanine Aminotransferase Ratio Scores, in Predicting Liver Histopathology. Turkish Journal of Internal Medicine 2021; 3(1): 6 doi: 10.46310/tjim.825814
|
| 5 |
Banu D. Ozel, Orhan K. Poyrazoğlu, Ahmet Karaman, Hatice Karaman, Engin Altinkaya, Eylem Sevinç, Gökmen Zararsiz. The PAPAS index. European Journal of Gastroenterology & Hepatology 2015; 27(8): 895 doi: 10.1097/MEG.0000000000000379
|
| 6 |
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunology 2018; 31(4): 315 doi: 10.1089/vim.2017.0134
|
| 7 |
Pinar Korkmaz, Nese Demirturk, Ayse Batırel, Ahmet Cem Yardimci, Unal Cagir, Salih Atakan Nemli, Fatime Korkmaz, Fusun Zeynep Akcam, Huseyin Sener Barut, Burcu Bayrak, Faruk Karakecili, Huseyin Tarakci, Zerrin Yulugkural, Esma Yuksel, Nazlım Aktug Demir, Onur Ural, Sua Sumer, Rezan Harman, Ayten Kadanali, Sinan Ozturk, Sila Cetin Akhan, Necla Eren Tulek, Derya Keten, Alper Sener, Bilgehan Aygen, Aysel Kocagul Celikbas, Fatma Yilmaz Karadag, Gule Aydin, Eyup Arslan, Cahide Sacligil, Gulfem Akengin Ocal, Alpaslan Tanoglu, Asim Ulcay, Ergenekon Karagoz, Nese Saltoglu, Fatma Sırmatel, Hayrettin Akdeniz, Aynur Aynıoglu, Selcan Arslan Ozel, Selmin Dirgen Caylak, Ilhami Celik, Yesim Alpay, Zehra Bestepe Dursun, Muhammed Bekcibasi, Gunay Tuncer Ertem, Arzu Tigli, Elif Sargin Altunok, Kemal Avsar, Kaya Suer, Murat Sayan. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey. Hepatitis Monthly 2017; (In Press) doi: 10.5812/hepatmon.60266
|
| 8 |
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1): e34934 doi: 10.1097/MD.0000000000034934
|
| 9 |
Julia C Drees, Soora Wi, Joanna B Ready, Richard S Dlott, Barbara J Fetterman, Suk I Seo, Mary Pat Pauly, Matthew S Petrie, Thomas S Lorey. Serum Fibrosis Marker Panels FIB-4 Index and Aspartate Aminotransferase (AST)-to-Platelet Ratio Index (APRI) Are Equivalent to AST Alone at Predicting Liver Fibrosis in a Cohort of 1731 Patients Infected with Hepatitis C Virus. The Journal of Applied Laboratory Medicine 2017; 2(1): 76 doi: 10.1373/jalm.2016.022509
|
| 10 |
Qing Pang, Jing-Yao Zhang, Xin-Sen Xu, Si-Dong Song, Wei Chen, Yan-Yan Zhou, Run-Chen Miao, Kai Qu, Su-Shun Liu, Ya-Feng Dong, Chang Liu. The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 2015; 75(1): 73 doi: 10.3109/00365513.2014.981759
|
| 11 |
Joanna Gorka-Dynysiewicz, Monika Pazgan-Simon, Jolanta Zuwala-Jagiello. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2639248
|
| 12 |
Barbara J. Turner, Chen-Pin Wang, Trisha V. Melhado, Raudel Bobadilla, Mamta K. Jain, Amit G. Singal. Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups. Clinical Gastroenterology and Hepatology 2019; 17(7): 1356 doi: 10.1016/j.cgh.2018.11.059
|
| 13 |
Roberta D’Ambrosio, Elisabetta Degasperi, Alessio Aghemo, Mirella Fraquelli, Pietro Lampertico, Maria Grazia Rumi, Floriana Facchetti, Eleonora Grassi, Giovanni Casazza, William Rosenberg, Pierre Bedossa, Massimo Colombo, Salvatore Petta. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLOS ONE 2016; 11(6): e0155967 doi: 10.1371/journal.pone.0155967
|
| 14 |
Barbara J. Turner, Yuanyuan Liang, Amit G. Singal. FIB-4 and imaging for measuring fibrosis in hepatitis C virus. European Journal of Gastroenterology & Hepatology 2017; 29(2): 192 doi: 10.1097/MEG.0000000000000766
|
| 15 |
Thabata Glenda Fenili Amorim, Guilherme Jönck Staub, César Lazzarotto, André Pacheco Silva, Joice Manes, Maria da Graça Ferronato, Maria Beatriz Cacese Shiozawa, Janaína Luz Narciso-Schiavon, Esther Buzaglo Dantas-Correa, Leonardo de Lucca Schiavon. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Annals of Hepatology 2012; 11(6): 855 doi: 10.1016/S1665-2681(19)31410-3
|
| 16 |
Shelley S Selph, Alexander D Ginsburg, Roger Chou. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Systematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-107
|
| 17 |
Meltem Öznur, Birol Topçu, Aliye Çelikkol. Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosis. European Journal of Gastroenterology & Hepatology 2021; 33(4): 577 doi: 10.1097/MEG.0000000000002045
|
| 18 |
Serpil Erdogan, Halef Okan Dogan, Sevilay Sezer, Sema Uysal, Esra Ozhamam, Serra Kayacetin, Yuksel Koca. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scandinavian Journal of Clinical and Laboratory Investigation 2013; 73(4): 300 doi: 10.3109/00365513.2013.773592
|
| 19 |
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
|
| 20 |
Ahmet Tarik Eminler, Talat Ayyildiz, Kader Irak, Murat Kiyici, Selim Gurel, Enver Dolar, Macit Gulten, Selim G. Nak. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. European Journal of Gastroenterology & Hepatology 2015; 27(12): 1361 doi: 10.1097/MEG.0000000000000468
|
| 21 |
G. Shiha, S. Seif, A. Eldesoky, M. Elbasiony, R. Soliman, A. Metwally, K. Zalata, N. Mikhail. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C. Hepatology International 2017; 11(3): 286 doi: 10.1007/s12072-017-9796-z
|
| 22 |
James F. Crismale, Valérie Martel‐Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich, Andrea D. Branch. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy. Liver International 2014; 34(7): 1018 doi: 10.1111/liv.12342
|
| 23 |
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
|